5AM Opportunities I, L.P.'s Net Worth

$0

Estimate Recalculated Jun 18, 2025 08:33PM EST

Who is 5AM Opportunities I, L.P.

5AM Opportunities I, L.P. does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Enliven Therapeutics, Inc., , Entrada Therapeutics, Inc., Vor Biopharma Inc., Pear Therapeutics, Inc., Rallybio Corp, scPharmaceuticals Inc., Akouos, Inc., IDEAYA Biosciences, Inc., IMPEL NEUROPHARMA INC, Cabaletta Bio, Inc., and Aprea Therapeutics, Inc..

SEC CIK

5AM Opportunities I, L.P.'s CIK is 0001753000

Past Insider Trading and Trends

No data available

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Entrada Therapeutics, Inc.

Investor
Updated Nov 04, 2021
Form 4
-74.71%
-23.62M
$20.00
Nov 04, 2021
7.99M
Buy-Options
Nov 02
Form 3
Oct 28, 2021
331.16K
Showing 2 results

Pear Therapeutics, Inc.

Investor
Updated Apr 12, 2023
Form 4
-98.81%
-16.54M
$0.12
-$1.99M
Apr 12, 2023
200.00K
Sale
Apr 10
Form 4
-0.78%
-105.28K
$2.74
-$288.27K
Nov 15, 2022
16.74M
Sale
Nov 11 - Nov 15
Form 4
-0.40%
-54.21K
$2.77
-$150.10K
Nov 02, 2022
16.85M
Sale
Oct 31 - Nov 02
Form 4
-3.96%
-558.17K
$1.88
-$1.05M
Sep 16, 2022
16.90M
Sale
Sep 14 - Sep 16
Form 4
-5.18%
-770.00K
$2.05
-$1.58M
Sep 08, 2022
17.46M
Sale
Sep 06 - Sep 08
Form 4
-2.62%
-400.00K
$1.65
-$660.06K
Aug 18, 2022
18.23M
Sale
Aug 16 - Aug 18
Form 3
Dec 13, 2021
18.63M
Showing 7 results

Rallybio Corp

Investor
Updated Jun 07, 2022
Form 4
-3.87%
-150.00K
$12.50
-$1.87M
Jun 07, 2022
3.73M
Sale
Jun 03
Form 4
-2.51%
-100.00K
$13.00
-$1.30M
May 25, 2022
3.88M
Sale
May 23
Form 4
-5.01%
-210.00K
$13.05
-$2.74M
Feb 10, 2022
3.98M
Sale
Feb 08
Form 4
77.83%
615.38K
$13.00
$8.00M
Aug 04, 2021
4.19M
Purchase
Aug 02
Form 3/A
Aug 04, 2021
3.58M
Form 3
Jul 29, 2021
3.57M
Showing 6 results

Akouos, Inc.

Investor
Updated Dec 02, 2022
Form 4
-100.00%
-4.14M
Dec 02, 2022
Disposition
Nov 30
Form 4
-10.20%
-470.00K
$18.00
-$8.46M
Dec 31, 2020
4.14M
Sale
Dec 29
Form 4
-94.93%
-86.25M
$17.00
Jul 02, 2020
4.61M
Buy-Options
Jun 30
Form 3
Jun 25, 2020
Showing 4 results

scPharmaceuticals Inc.

Investor
Updated Oct 11, 2022
Form 4
-17.99%
-600.00K
$4.15
-$2.49M
Oct 11, 2022
2.73M
Sale
Oct 06 - Oct 10
Form 4
-6.36%
-226.62K
$4.84
-$1.10M
Sep 08, 2022
3.33M
Sale
Sep 06 - Sep 07
Form 4
-7.05%
-270.00K
$5.00
-$1.35M
Apr 13, 2022
3.56M
Sale
Apr 11
Form 3
May 28, 2020
578.03K
Showing 4 results

IDEAYA Biosciences, Inc.

Investor
Updated Nov 13, 2020
Form 4
-23.10%
-800.00K
$13.66
-$10.93M
Nov 13, 2020
2.66M
Sale
Nov 11
Showing 1 results

IMPEL NEUROPHARMA INC

Investor
Updated Apr 29, 2021
Form 4
-92.31%
-34.63M
$14.25
$8.63M
Apr 29, 2021
2.88M
Buy-Options
Apr 27
Showing 1 results

Cabaletta Bio, Inc.

Investor
Updated Nov 03, 2021
Form 4
-12.50%
-295.00K
$13.00
-$3.83M
Nov 03, 2021
2.06M
Sale
Nov 01
Form 4
-23.90%
-625.00K
$9.70
-$6.06M
Sep 09, 2021
2.36M
Sale
Sep 07
Form 4
-6.01%
-387.00K
$13.00
-$5.03M
Jan 12, 2021
6.05M
Sale
Jan 08 - Jan 12
Form 4
-8.12%
-298.00K
$14.75
-$4.40M
Dec 14, 2020
3.37M
Sale
Dec 10
Form 4
-23.91%
-1.15M
$11.00
$5.00M
Oct 31, 2019
3.67M
Buy-Options
Oct 29
Showing 5 results

Aprea Therapeutics, Inc.

Investor
Updated Oct 07, 2020
Form 4
-55.82%
-175.00K
$25.30
-$4.43M
Oct 07, 2020
2.04M
Sale
Oct 05
Form 4
-5.95%
-140.00K
$33.30
-$4.66M
Jun 18, 2020
2.21M
Sale
Jun 16
Form 4
-10.82%
-245.00K
$28.75
-$7.04M
Jun 15, 2020
2.35M
Sale
Jun 11
Form 4
-10.12%
-255.00K
$35.15
-$8.96M
May 21, 2020
2.60M
Sale
May 19
Form 4
7.37%
333.33K
$15.00
$5.00M
Oct 09, 2019
4.86M
Purchase
Oct 07
Showing 5 results

Enliven Therapeutics, Inc.

Investor
Updated Feb 16, 2024
Form 4
-17.70%
-825.00K
$14.90
-$12.29M
Feb 16, 2024
3.84M
Sale
Feb 14
Form 4
-9.69%
-500.00K
$15.00
-$7.50M
Feb 02, 2024
4.66M
Sale
Jan 31
Form 4
-3.69%
-197.50K
$15.00
-$2.96M
Sep 28, 2023
5.16M
Sale
Sep 26
Form 4
-7.59%
-440.00K
$16.00
-$7.04M
Aug 28, 2023
5.36M
Sale
Aug 24
Form 3
Mar 06, 2023
5.80M
Showing 5 results

Investor
Updated Feb 28, 2023
Form 4
-100.00%
-4.94M
Feb 28, 2023
Disposition
Feb 24
Form 4
15.62%
600.00K
$30.00
$18.00M
Aug 17, 2022
4.94M
Purchase
Aug 15
Form 4
-67.01%
-8.81M
$16.00
Jan 13, 2022
4.34M
Buy-Options
Jan 11
Form 3
Jan 06, 2022
Showing 4 results

Vor Biopharma Inc.

Investor
Updated Nov 18, 2021
Form 4
-4.94%
-330.71K
$15.30
-$5.06M
Nov 18, 2021
6.36M
Sale
Nov 16
Form 4
-91.98%
-76.77M
$18.00
Feb 09, 2021
6.69M
Buy-Options
Feb 09
Form 3
Feb 04, 2021
Showing 3 results